Dr. Donald Kufe received his MD in 1970 from the University of Rochester School of Medicine. After a clinical fellowship in medical oncology at Dana-Farber Cancer Institute, he joined the staff in 1979. He has served as Chief of the Division of Cancer Pharmacology, Deputy Director of the Dana-Farber Cancer Center, Director of the Harvard Phase I Oncology Group, and Leader of the Experimental Therapeutics Program. He was awarded the Faculty Research Award, American Cancer Society in 1982; Scholar Award, Burroughs-Wellcome in 1986; and Scientific Merit Award, Lung Cancer Research Foundation in 2010. Translational research in the Dr. Kufe laboratory is focused on the development of approaches that block MUC1-C subunit function with soluble receptors and antibodies against the MUC1-C extracellular domain. He is an editor of the textbook “Cancer Medicine.”